Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-18 Sale |
2021-05-19 8:18 pm |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
57,763 | $24.15 | $1,394,769 | 196,087 (Direct) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:59 pm |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
425,000 | $19 | $8,075,000 | 3,270,544 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:35 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
1,160,000 | $19 | $22,040,000 | 1,160,000 (Indirect) |
View |
| 2020-11-19 Purchase |
2020-11-20 8:02 pm |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
1,135,334 | $19 | $21,571,346 | 500,642 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-31 Other |
2021-05-26 9:37 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
99,556 | $0 | 6,615,682 (Indirect) |
View |
| 2021-05-18 Exercise |
2021-05-19 8:18 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
57,763 | $2.064 | 196,087 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-19 8:18 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney CHIEF BUSINESS OFFICER |
57,763 | $0 | 196,087 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 7:49 pm |
N/A 2031-04-04 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
25,293 | $0 | 25,293 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-16 7:07 pm |
N/A 2031-03-14 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney Chief Business Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-16 7:05 pm |
N/A 2031-03-14 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-24 5:36 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
1,725,406 | $0 | 1,725,406 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:59 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
5,691,088 | $0 | 3,270,544 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:35 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
2,583,875 | $0 | 1,160,000 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:35 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
448,556 | $0 | 481,014 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:34 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer |
167,677 | $0 | 746,667 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:33 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | MCCORMICK FRANK Director |
219,217 | $0 | 275,373 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:32 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Kushner Peter J. Chief Scientific Officer |
358,920 | $0 | 1,431,672 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:31 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer |
193,402 | $0 | 1,233,574 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 8:02 pm |
N/A 2030-11-17 |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
64,560 | $0 | 500,642 (Indirect) |
View |
| 2020-11-19 Conversion |
2020-11-20 8:02 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
5,216,676 | $0 | 500,642 (Direct) |
View |
| 2020-11-18 Option Award(A) |
2020-11-20 6:42 pm |
N/A 2030-11-17 |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer |
1,076 | $0 | 1,076 (Indirect) |
View |
| 2020-09-18 Option Award |
2020-11-19 7:00 pm |
N/A 2030-09-17 |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
78,484 | $0 | 78,484 (Direct) |
View |
| 2020-09-19 Option Award |
2020-11-19 6:57 pm |
N/A 2030-09-18 |
Olema Pharmaceuticals Inc. | OLMA | Moriarty John B EVP, Ch. Legal Officer & Sec. |
413,466 | $0 | 413,466 (Direct) |
View |
| 2020-09-18 Option Award |
2020-11-19 6:56 pm |
N/A 2030-09-17 |
Olema Pharmaceuticals Inc. | OLMA | MCCORMICK FRANK Director |
78,484 | $0 | 78,484 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-19 6:46 pm |
N/A 2030-11-17 |
Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director |
64,560 | $0 | 64,560 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-19 6:44 pm |
N/A 2030-11-17 |
Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director |
86,083 | $0 | 86,083 (Direct) |
View |
| 2020-08-12 Option Award |
2020-11-19 6:42 pm |
N/A 2030-08-11 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
231,210 | $0 | 231,210 (Direct) |
View |
| 2020-08-12 Option Award |
2020-11-19 6:42 pm |
N/A 2030-08-11 |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
105,396 | $0 | 189,272 (Direct) |
View |
| 2020-09-16 Exercise |
2020-11-19 6:42 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
83,876 | $4.406 | 189,272 (Direct) |
View |
| 2020-09-16 Exercise |
2020-11-19 6:42 pm |
N/A 2030-08-11 |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
83,876 | $0 | 189,272 (Direct) |
View |
| 2020-09-19 Option Award |
2020-11-19 6:41 pm |
N/A 2030-09-18 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
1,648,916 | $0 | 2,676,881 (Direct) |
View |
| 2020-09-23 Exercise |
2020-11-19 6:41 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
51,649 | $4.824 | 2,676,881 (Direct) |
View |
| 2020-09-23 Exercise |
2020-11-19 6:41 pm |
N/A 2030-09-18 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
51,649 | $0 | 2,676,881 (Direct) |
View |
Ownership |
2020-11-19 5:43 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
0 | $0 | 573,846 (Indirect) |
View |
Ownership |
2020-11-19 08:49 am |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner |
0 | $0 | 5,216,676 (Direct) |
View |
Ownership |
2020-11-18 6:46 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
0 | $0 | 1,725,406 (Direct) |
View |
Ownership |
2020-11-18 6:41 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
0 | $0 | 2,583,875 (Indirect) |
View |
Ownership |
2020-11-18 6:25 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer |
0 | $0 | 759,498 (Direct) |
View |
Ownership |
2020-11-18 6:25 pm |
N/A 2030-09-18 |
Olema Pharmaceuticals Inc. | OLMA | Moriarty John B EVP, Ch. Legal Officer & Sec. |
0 | $0 | 252,060 (Direct) |
View |
Ownership |
2020-11-18 6:24 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | MCCORMICK FRANK Director |
0 | $0 | 350,271 (Direct) |
View |
Ownership |
2020-11-18 6:23 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Kushner Peter J. Chief Scientific Officer |
0 | $0 | 1,431,672 (Direct) |
View |
Ownership |
2020-11-18 6:23 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles Ch. Operating & Financial Off. |
0 | $0 | 358,680 (Direct) |
View |
Ownership |
2020-11-18 6:20 pm |
N/A 2030-06-09 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney Chief Business Officer |
0 | $0 | 252,060 (Direct) |
View |
Ownership |
2020-11-18 6:19 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer |
0 | $0 | 1,461,433 (Direct) |
View |
Ownership |
2020-11-18 6:18 pm |
N/A 2030-08-11 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
0 | $0 | 209,690 (Direct) |
View |
Ownership |
2020-11-18 6:17 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
0 | $0 | 83,876 (Direct) |
View |
Ownership |
2020-11-18 6:17 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
0 | $0 | 1,110,896 (Direct) |
View |